245 related articles for article (PubMed ID: 35144669)
21. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
22. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.
Citro S; Bellini A; Miccolo C; Ghiani L; Carey TE; Chiocca S
Br J Cancer; 2019 Mar; 120(6):658-667. PubMed ID: 30765872
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
Uehara K; Tanabe Y; Hirota S; Higa S; Toyoda Z; Kurima K; Kina S; Nakasone T; Arasaki A; Kinjo T
BMC Cancer; 2021 Jun; 21(1):688. PubMed ID: 34112111
[TBL] [Abstract][Full Text] [Related]
24. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
[TBL] [Abstract][Full Text] [Related]
25. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
[No Abstract] [Full Text] [Related]
26. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
27. Enhanced radiation sensitivity in HPV-positive head and neck cancer.
Kimple RJ; Smith MA; Blitzer GC; Torres AD; Martin JA; Yang RZ; Peet CR; Lorenz LD; Nickel KP; Klingelhutz AJ; Lambert PF; Harari PM
Cancer Res; 2013 Aug; 73(15):4791-800. PubMed ID: 23749640
[TBL] [Abstract][Full Text] [Related]
28. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
29. Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Nulton TJ; Olex AL; Dozmorov M; Morgan IM; Windle B
Oncotarget; 2017 Mar; 8(11):17684-17699. PubMed ID: 28187443
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
31. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
34. Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
Banerjee NS; Moore D; Parker CJ; Broker TR; Chow LT
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683862
[TBL] [Abstract][Full Text] [Related]
35. Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling.
Bristol ML; Das D; Morgan IM
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934154
[TBL] [Abstract][Full Text] [Related]
36. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
37. Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.
Wallace NA; Galloway DA
Semin Cancer Biol; 2014 Jun; 26():30-42. PubMed ID: 24412279
[TBL] [Abstract][Full Text] [Related]
38. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
39. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
